Find the gaps together with us at the ProPharma Group Centre of Excellence; a life cycle approach
Will your clinical development in the future deliver new treatment options? Solid science will always be a foundation, but a successful development process stretches beyond scientific opportunities. Find the gaps and apply a life cycle approach for product development.
Professor Doctor Annemieke Aartsma-Rus will inform you on the lessons learned from a failure of a registration trial on a Duchenne muscular dystrophy treatment.
Step into the world of Phase II studies based on a multidisciplinary approach and strategy building. Discuss topics as dose finding, comparator picking, epidemiology, and dosing formulations. Focus on small (Phase II/III) studies on rare diseases.
16.30 Doors open
17.15 – 18.15 Annemieke Aartsma-Rus (Professor of translational genetics, LUMC),
Therapy development for rare diseases takes more than a therapeutic
18.15 – 19.00 Thomas de Vlaam (Founder and CEO, Amylon Therapeutics): Industry
19.00 – 19.30 ProPharma Group: Regulatory affairs
19.30 Drinks & Networking
Register for free at email@example.com